Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities

Acute myocardial infarction (AMI) and the heart failure that often follows, are major causes of death and disability worldwide. As such, new therapies are required to limit myocardial infarct (MI) size, prevent adverse left ventricular (LV) remodeling, and reduce the onset of heart failure following...

Descripción completa

Detalles Bibliográficos
Autores principales: Ong, Sang-Bing, Hernández-Reséndiz, Sauri, Crespo-Avilan, Gustavo E., Mukhametshina, Regina T., Kwek, Xiu-Yi, Cabrera-Fuentes, Hector A., Hausenloy, Derek J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pergamon Press 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5981007/
https://www.ncbi.nlm.nih.gov/pubmed/29330085
http://dx.doi.org/10.1016/j.pharmthera.2018.01.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5981007/
https://www.ncbi.nlm.nih.gov/pubmed/29330085
http://dx.doi.org/10.1016/j.pharmthera.2018.01.001

Ejemplares similares